{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:33:46Z","timestamp":1794004426151,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.vaccine.2024.05.072","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T11:36:51Z","timestamp":1717501011000},"page":"126024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Real-world safety data for MVA-BN: Increased frequency of syncope following intradermal administration for immunization against mpox disease"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6866-4028","authenticated-orcid":false,"given":"Heinz","family":"Weidenthaler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Vidojkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"De Moerlooze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.05.072_b0005","unstructured":"World Health Organization. WHO Director-General declares the ongoing monkeypox outbreak a Public Health Emergency of International Concern 2023. https:\/\/www.who.int\/europe\/news\/item\/23-07-2022-who-director-general-declares-the-ongoing-monkeypox-outbreak-a-public-health-event-of-international-concern (accessed January 4, 2023)."},{"key":"10.1016\/j.vaccine.2024.05.072_b0010","unstructured":"World Health Organization. Vaccines and immunization for monkeypox: interim guidance, 16 November 2022 2023. https:\/\/www.who.int\/publications\/i\/item\/WHO-MPX-Immunization (accessed January 4, 2023)."},{"issue":"39","key":"10.1016\/j.vaccine.2024.05.072_b0015","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1016\/j.vaccine.2015.06.075","article-title":"Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-na\u00efve subjects","volume":"33","author":"Frey","year":"2015","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2024.05.072_b0020","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMc2215846","article-title":"Erythema and induration after mpox (JYNNEOS) vaccination revisited","volume":"388","author":"Frey","year":"2023","journal-title":"N Engl J Med Overseas Ed"},{"issue":"3","key":"10.1016\/j.vaccine.2024.05.072_b0025","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41591-023-02229-3","article-title":"Real-world effectiveness of a single dose of mpox vaccine in males","volume":"29","author":"Wolff Sagy","year":"2023","journal-title":"Nat. Med."},{"issue":"49","key":"10.1016\/j.vaccine.2024.05.072_b0030","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.15585\/mmwr.mm7149a5","article-title":"Reduced risk for mpox after receipt of 1 or 2 doses of JYNNEOS vaccine compared with risk among unvaccinated persons \u2014 43 U.S. jurisdictions, July 31\u2013October 1, 2022","volume":"71","author":"Payne","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"20","key":"10.1016\/j.vaccine.2024.05.072_b0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.15585\/mmwr.mm7220a3","article-title":"Estimated effectiveness of JYNNEOS vaccine in preventing mpox: a multijurisdictional case-control study \u2014 United States, August 19, 2022\u2013March 31, 2023","volume":"72","author":"Dalton","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"26","key":"10.1016\/j.vaccine.2024.05.072_b0040","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","article-title":"Vaccine effectiveness of JYNNEOS against mpox disease in the United States","volume":"388","author":"Deputy","year":"2023","journal-title":"N Engl J Med Overseas Ed"},{"issue":"20","key":"10.1016\/j.vaccine.2024.05.072_b0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.15585\/mmwr.mm7220a4","article-title":"Effectiveness of JYNNEOS vaccine against diagnosed mpox infection \u2014 New York, 2022","volume":"72","author":"Rosenberg","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"24","key":"10.1016\/j.vaccine.2024.05.072_b0050","article-title":"Post-exposure vaccine effectiveness and contact management in the mpox outbreak, Madrid, Spain, May to August 2022","volume":"28","author":"Morales","year":"2023","journal-title":"Eurosurveillance"},{"issue":"2","key":"10.1016\/j.vaccine.2024.05.072_b0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/cid\/ciad645","article-title":"Effectiveness of Modified Vaccinia Ankara-Bavarian Nordic vaccination in a population at high risk of mpox: a Spanish cohort study","volume":"78","author":"Font\u00e1n-Vela","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2024.05.072_b0060","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad528","article-title":"Effectiveness of the modified vaccinia Ankara vaccine against mpox in men who have sex with men: a retrospective cohort analysis, Seattle, Washington","volume":"10","author":"Ramchandani","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2024.05.072_b0065","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(23)00057-9","article-title":"Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study","volume":"23","author":"Bertran","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2024.05.072_b0070","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/cid\/ciad584","article-title":"Single-dose effectiveness of mpox vaccine in Quebec, Canada: test-negative design with and without adjustment for self-reported exposure risk","volume":"78","author":"Brousseau","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.072_b0075","doi-asserted-by":"crossref","unstructured":"Haverkate MR, Willemstein IJ, van Ewijk CE, Adam PC, Lanooij SJ, Jonker-Jorna P, van Bokhoven C, van Rijckevorsel GG, Hoornenborg E, David S, Mollema L, Te Wierik MJ, Lange J, Franz E, de Melker HE, Op de Coul EL, Hahn\u00e9 SJ. Factors potentially contributing to the decline of the mpox outbreak in the Netherlands, 2022 and 2023. Euro Surveill. 2024 May;29(21):2300608.","DOI":"10.2807\/1560-7917.ES.2024.29.21.2300608"},{"key":"10.1016\/j.vaccine.2024.05.072_b0080","doi-asserted-by":"crossref","unstructured":"Navarro C, Lau C, Buchan SA, Burchell AN, Nasreen S, Friedman L, et al. Effectiveness of one dose of MVA-BN vaccine against mpox infection in males in Ontario, Canada: a target trial emulation. medRxiv [preprint] [Internet]; 2023. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2023.10.04.23296566v1 (accessed February 23, 2024).","DOI":"10.1101\/2023.10.04.23296566"},{"issue":"24","key":"10.1016\/j.vaccine.2024.05.072_b0085","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1001\/jama.289.24.3283","article-title":"Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel","volume":"289","author":"Halsell","year":"2003","journal-title":"J Am Med Assoc"},{"issue":"9","key":"10.1016\/j.vaccine.2024.05.072_b0090","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2003.11.053","article-title":"Smallpox vaccination and myopericarditis: a clinical review","volume":"43","author":"Cassimatis","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.05.072_b0095","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.vaccine.2020.12.046","article-title":"Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990\u20132018","volume":"39","author":"Su","year":"2021","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2024.05.072_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118283","article-title":"A prospective study of the incidence of myocarditis\/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination","volume":"10","author":"Engler","year":"2015","journal-title":"PLoS One"},{"issue":"39","key":"10.1016\/j.vaccine.2024.05.072_b0105","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1016\/j.vaccine.2021.08.041","article-title":"Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members","volume":"39","author":"Decker","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2024.05.072_b0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7205\/MILMED-D-12-00226","article-title":"Myopericarditis and pericarditis in the deployed military member: a retrospective series","volume":"178","author":"Lin","year":"2013","journal-title":"Mil Med"},{"issue":"25","key":"10.1016\/j.vaccine.2024.05.072_b0115","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJM200012213432507","article-title":"Syncope","volume":"343","author":"Kapoor","year":"2000","journal-title":"N Engl J Med Overseas Ed"},{"issue":"3","key":"10.1016\/j.vaccine.2024.05.072_b0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jce.13810","article-title":"Understanding vasovagal syncope akin to the philosopher\u2019s stone?","volume":"30","author":"Fedorowski","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.vaccine.2024.05.072_b0125","unstructured":"Committee to Review Adverse Effects of Vaccines; Institute of Medicine. Adverse effects of vaccines: evidence and causality. In: Stratton K, Ford A, Rusch E, Clayton EW, editors. Washington, DC: The National Academies Press; 2011."},{"issue":"49","key":"10.1016\/j.vaccine.2024.05.072_b0130","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.15585\/mmwr.mm7149a4","article-title":"Safety monitoring of JYNNEOS vaccine during the 2022 mpox outbreak \u2014 United States, May 22\u2013October 21, 2022","volume":"71","author":"Duffy","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2024.05.072_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195897","article-title":"Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: a randomised, double blind, placebo controlled phase III trial","volume":"13","author":"Overton","year":"2018","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.vaccine.2024.05.072_b0140","first-page":"457","article-title":"Syncope after vaccination\u2013United States, January 2005-July 2007","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.05.072_b0145","doi-asserted-by":"crossref","unstructured":"Hause AM, Gee J, Johnson T, Jazwa A, Marquez P, Miller E, et al. Anxiety-related adverse event clusters after Janssen COVID-19 vaccination \u2014 five U.S. mass vaccination sites, April 2021. MMWR Morb Mortal Wkly Rep 2021;70(18):685\u20138.","DOI":"10.15585\/mmwr.mm7018e3"},{"issue":"9","key":"10.1016\/j.vaccine.2024.05.072_b0150","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e67","article-title":"Estimating baseline incidence of conditions potentially associated with vaccine adverse events: a call for surveillance system using the Korean national health insurance claims data","volume":"36","author":"Huh","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2024.05.072_b0155","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/joa3.12721","article-title":"Frequency of vaccine-associated syncope after COVID-19 vaccination in adolescents","volume":"38","author":"Takase","year":"2022","journal-title":"J Arrhythm"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T22:09:16Z","timestamp":1737583756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24006510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":31,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0264410X24006510"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world safety data for MVA-BN: Increased frequency of syncope following intradermal administration for immunization against mpox disease","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126024"}}